Lenoflox

Levofloxacin hemihydrate.

Each film-coated tablet contains: 512 mg of Levofloxacin hemihydrate equivalent to 500 mg Levofloxacin.

Antibacterial (Third Generation Quinolones).
Pharmacology: Pharmacokinetics: Levofloxacin is rapidly and almost completely absorbed following oral administration with peak plasma concentrations achieved within an hour of a dose. It is distributed into body tissues including the bronchial mucosa and lungs, but penetration into CSF is relatively poor. Levofloxacin is approximately 30 to 40% bound to plasma proteins. It is only metabolized to a small degree to inactive metabolites. The elimination half-life of levofloxacin is 6 to 8 hours, although this may be prolonged in patients with renal impairment. Levofloxacin is excreted largely unchanged, primarily in the urine. It is not removed by haemodialysis or peritoneal dialysis.

Acute maxillary sinusitis due to Streptococcus pneumoniae, Haemophilus influenzae or Moraxella catarrhalis etc.
Acute bacterial exacerbation of chronic bronchitis (ABECB) due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis etc.
Nosocomial pneumonia due to methicillin-susceptible Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, E. coli, Klebsiella pneumoniae, Haemophilus influenzae, or Streptococcus pneumoniae etc.
Community-acquired pneumonia (CAP) due to Klebsiella pneumoniae, Chlamydia pneumoniae, Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae or Moraxella catarrhalis etc.
Complicated and uncomplicated urinary tract infections due to E. coli, Klebsiella pneumoniae, Staphylococcus aureus or Staphylococcus aprophyticus, Proteus mirabilis, Enterococcus faecalis or Enterobacter cloacae etc.
Acute pyelonephritis due to E. coli etc.
Complicated and uncomplicated skin and skin structure infections including abscesses, cellulitis, furuncles, wound infection, impetigo and pyoderma due to Staphylococcus aureus, Streptococcus pyogenes, Proteus mirabilis or Enterococcus faecalis etc.
Chronic bacterial prostatitis due to Enterococcus faecalis, E. coli, or Staphylococcus epidermidis etc.

Levofloxacin can be administered without regards to food.
The usual dose of Levofloxacin is 500 mg once or twice daily. (See table.)

Click on icon to see table/diagram/image

Levofloxacin is contraindicated in patients with a history of hypersensitivity to Levofloxacin, quinolones or any other components of this product.

Levofloxacin cause degenerative changes in weight-bearing joints of young animals, it has been suggested that these compounds should not be used in children, adolescents, pregnant women, or breast-feeding mothers. Tendon damage may occur rarely with fluoroquinolones, and treatment should be discontinued if patients experience tendon pain, inflammation, or rupture.
Care is necessary in patients with impaired hepatic or renal function, glucose-6-phosphate dehydrogenase deficiency, or myasthenia gravis. An adequate fluid intake should be maintained during treatment with ciprofloxacin and excessive alkalinity of the urine avoided because of the risk of crystalluria. Exposure to strong sunlight or sunlamps should also be avoided. The ability to drive or operate machinery may be impaired.
Levofloxacin can increase the occurrence of rare but serious events or ruptures or tears in the aorta. These tears or ruptures on an aortic aneurysm can lead to dangerous bleeding or death.
Healthcare professionals are advised to avoid prescribing Levofloxacin to patients who have aortic aneurysm or at risk for an aortic aneurysm, such as patients with peripheral atherosclerotic vascular disease, hypertension, certain genetic conditions such as Marfan syndrome and Ehlers-Danlos syndrome, and elderly patients. The benefit of using Levofloxacin to these patients should be assessed by the prescribers prior to initiation of therapy. It should be prescribed to these patients only when no other treatment options are available.
Seek immediate medical treatment for any symptoms associated with aortic aneurysm and stop the Levofloxacin therapy immediately if suggestive of aortic aneurysm or dissection.

It has been suggested that these compounds should not be used in pregnant women, or breast-feeding mothers.

Levofloxacin is generally well tolerated but it may cause a few side effects such as gastrointestinal disturbances including nausea, vomiting, diarrhea, abdominal pain and dyspepsia and CNS side effects including headache, dizziness, restlessness, nervousness & insomnia. Pruritus, rash & erythema may also occur occasionally.

Interact with theophylline, warfarin, cyclosporin, digoxin, probenecid, cimetidine, sucralfate, antacid, NSAIDs.

Store at temperatures not exceeding 30°C.

Quinolones

J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.

Rx